NCT00601900-D1
Dataset Information
Dataset ID: NCT00601900-D1
PubMed ID (PMID):
Publication Title:
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
Description of Dataset:
NCT00601900-D1 (efficacy) contains one observation per patient enrolled in Phase III Letrozole trial (N=350). The data contained allows you to reproduce the efficacy data on the N=343 randomized and treated patients (use code treated=1 to identify).
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT00601900 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®